This content is not available in your region

UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

Access to the comments Comments
By Reuters
UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine   -   Copyright  Thomson Reuters 2021

– The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency’s website showed on Thursday.

Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.